Lab Interpretation

Systematic interpretation of common laboratory tests across hematology, chemistry, coagulation, microbiology, endocrinology, and toxicology. Reference ranges, critical values, abnormal patterns, and the differential diagnoses needed to act on lab results.

01 Reference Ranges & Critical Values

Laboratory interpretation is the core cognitive skill that translates a column of numbers into a diagnosis, a treatment, or an urgent phone call. Every lab result must be interpreted in the context of the patient, the pre-test probability, the assay characteristics, and the timing of the measurement. A number outside the reference range is not automatically pathologic; a number inside the reference range is not automatically reassuring.

Why This Matters

Clinicians order billions of lab tests annually, and the majority of diagnostic errors involve either failure to order the right test, failure to act on an abnormal result, or misinterpretation of a normal result in a sick patient. Mastery of lab interpretation is the single highest-yield clinical skill for avoiding diagnostic error.

Reference Range Definitions

A reference range is typically defined as the central 95% of values from a healthy reference population — meaning that by definition, 5% of healthy individuals will fall outside any given reference interval. When multiple independent tests are ordered (e.g., a 14-analyte CMP), the probability that at least one result will fall outside the reference range purely by chance exceeds 50%. This statistical reality is why interpretation must always be anchored to clinical pre-test probability, not to reference range flags alone.

A "borderline abnormal" result on a comprehensive panel in an asymptomatic patient is more likely to represent statistical noise than disease. Repeat testing before launching an expensive workup on a single mildly abnormal value in a well patient.

Critical Values Requiring Immediate Action

AnalyteCritical LowCritical High
Sodium<120 mmol/L>160 mmol/L
Potassium<2.8 mmol/L>6.2 mmol/L
Glucose<40 mg/dL>500 mg/dL
Calcium (total)<6.5 mg/dL>13.0 mg/dL
Magnesium<1.0 mg/dL>4.7 mg/dL
Hemoglobin<6.5 g/dL>20 g/dL
Platelets<20 ×109/L>1000 ×109/L
WBC<1.0 ×109/L>50 ×109/L
INR>5.0
pH<7.20>7.60
PaO2<55 mmHg
PaCO2<20 mmHg>70 mmHg
Troponin I/T>99th percentile (assay-specific)
Lactate>4 mmol/L
Critical values require documented verbal communication to the ordering clinician, not just a chart entry. If you receive a critical value call, verify the sample is not hemolyzed or mislabeled before acting, but never delay therapy when the clinical picture matches.

The Gaussian Trap

Many lab values are not normally distributed — they are skewed (ferritin, triglycerides, liver enzymes, hormones). Reference intervals derived by assuming a Gaussian distribution may misrepresent the true 2.5th and 97.5th percentiles, leading to overcalling "abnormality" on one tail and underestimating it on the other. Log-transformed reference intervals are more accurate for skewed analytes, but not every lab reports them. Clinically, this means that a ferritin of 15 ng/mL may be flagged "normal" while already representing iron depletion, and an ALT of 35 U/L may be flagged "normal" while being inappropriately high for a thin, healthy young woman.

Age, Sex & Population-Specific Ranges

AnalyteVariation
CreatinineLower in women, elderly, low muscle mass; higher in muscular young men
Alkaline phosphatase2–3× adult normal in children and adolescents (growth plates)
HemoglobinLower in women, pregnancy (dilutional), infants after 2 months (physiologic nadir)
TSHGestational-age-specific ranges in pregnancy; higher upper limit in elderly
D-dimerRises with age; use age-adjusted cutoff (age × 10 ng/mL >50 yr)
BNP / NT-proBNPHigher in women, elderly, CKD; lower in obesity
TroponinSex-specific 99th percentiles with high-sensitivity assays

Units: Conventional vs SI

US laboratories typically report in conventional units (mg/dL, g/dL, μg/mL), while most of the world uses SI units (mmol/L, g/L, μmol/L). Common conversions worth memorizing: creatinine mg/dL × 88.4 = μmol/L; glucose mg/dL × 0.0555 = mmol/L; calcium mg/dL × 0.25 = mmol/L; bilirubin mg/dL × 17.1 = μmol/L. Misreading the units (mg/dL vs mg/L) is a classic source of 10-fold dosing errors.

02 Test Characteristics & Bayesian Reasoning

Every diagnostic test has four fundamental characteristics that govern its clinical utility: sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Sensitivity and specificity are properties of the test itself; predictive values depend on the prevalence (pre-test probability) of disease in the population being tested.

The Core Definitions

MetricFormulaInterpretation
SensitivityTP / (TP + FN)Probability a diseased patient tests positive; high sensitivity rules disease OUT when negative (SnNout)
SpecificityTN / (TN + FP)Probability a healthy patient tests negative; high specificity rules disease IN when positive (SpPin)
PPVTP / (TP + FP)Probability of disease given a positive test; increases with prevalence
NPVTN / (TN + FN)Probability of no disease given a negative test; decreases with prevalence
LR+Sens / (1 − Spec)How much a positive test raises post-test odds; >10 is strong
LR−(1 − Sens) / SpecHow much a negative test lowers post-test odds; <0.1 is strong

Bayesian Reasoning in Practice

Post-test probability = (pre-test odds × likelihood ratio) converted back to probability. The clinical implication: a highly sensitive and specific test is useless when applied to a population with extremely low pre-test probability, because even a small false-positive rate will produce more false positives than true positives. This is the mathematics behind "don't order a d-dimer on a patient with PERC-negative low-probability PE" and "don't screen 20-year-olds for prostate cancer."

Worked Example

D-dimer has ~95% sensitivity and ~50% specificity for PE. In a Wells low-probability patient (pre-test probability ~5%), a negative d-dimer drops post-test probability to <1%, effectively ruling out PE. In a Wells high-probability patient (pre-test probability ~40%), the same negative d-dimer still leaves post-test probability around 7–10%, too high to defer imaging. Same test, same result, different action — because Bayes.

Sources of Diagnostic Error

Common Bayesian errors include base rate neglect (forgetting that a rare disease remains rare even after a positive test), anchoring (sticking with an initial impression despite contrary data), and the representativeness heuristic (matching the patient to a classic vignette while ignoring prevalence). The correct approach is to explicitly estimate pre-test probability before ordering the test, choose the test whose likelihood ratio will move probability across an action threshold, and then update.

If a test result will not change management regardless of whether it is positive or negative, do not order the test. This single rule eliminates the majority of low-value testing.

Screening vs Diagnostic Testing

A screening test is applied to an asymptomatic population and should prioritize high sensitivity (minimizing false negatives, accepting more false positives which will be adjudicated by confirmatory testing). A diagnostic test is applied to a symptomatic or higher-risk population and should prioritize high specificity and positive likelihood ratio. Mismatching the test to the context (ordering screening tests in high-prevalence populations, or diagnostic tests in asymptomatic people) produces predictable errors. For example, HIV screening uses a highly sensitive ELISA; a positive is confirmed with a specific Western blot or differentiation assay. Troponin in the emergency department is used diagnostically, with serial changes at tight thresholds.

Reflex & Cascade Testing

Many labs run reflex algorithms: a positive HIV screen automatically triggers confirmatory testing; a high TSH reflexes to free T4; a positive hepatitis C antibody reflexes to HCV RNA. Understanding these algorithms prevents unnecessary duplicate orders and ensures appropriate follow-up. Cascade testing (one abnormal result triggering an ever-widening workup) must be resisted unless each step is clinically justified — otherwise a single borderline value snowballs into thousands of dollars of testing.

03 Pre-Analytic Errors & Specimen Integrity

The majority of laboratory errors occur not in the analyzer but in the pre-analytic phase — during specimen collection, handling, labeling, and transport. A hemolyzed sample, a mislabeled tube, or a delayed transport can invalidate a result entirely or produce a spuriously abnormal value that triggers unnecessary intervention.

Tube Color, Additive & Purpose

Tube ColorAdditiveCommon Tests
RedNone (serum)Chemistries, serology, drug levels
Gold / Tiger (SST)Clot activator + gelMost chemistries, troponin, lipids
Light BlueSodium citrate (3.2%)PT/INR, aPTT, fibrinogen, d-dimer
GreenLithium or sodium heparinPlasma chemistries, ammonia, ionized Ca
Lavender / PurpleEDTA (K2 or K3)CBC, HbA1c, blood typing, lead
GraySodium fluoride + potassium oxalateGlucose, lactate, alcohol
Royal BlueTrace-element freeHeavy metals, zinc, copper
Yellow (ACD)Acid citrate dextroseHLA typing, flow cytometry

Hemolysis, Lipemia & Icterus

Hemolysis releases intracellular contents into serum, spuriously elevating potassium, LDH, AST, phosphate, and magnesium, while decreasing sodium by dilution. Potassium in particular can rise 0.5–1.0 mmol/L with visible hemolysis and far higher with severe hemolysis. Never treat "hyperkalemia" on a hemolyzed sample without a repeat draw — the classic error is pushing calcium gluconate and insulin on a patient with a pristine heart and a pristine serum potassium.

Lipemia (turbid post-prandial sample or hypertriglyceridemia) interferes optically, falsely depressing sodium (pseudohyponatremia) on certain analyzers, and distorting many spectrophotometric assays. Icterus (high bilirubin) interferes with creatinine by Jaffe method, lipids, and total protein.

Classic Pre-Analytic Traps

ErrorEffectPrevention
Tourniquet >1 minFalsely ↑ potassium, calcium, protein, bilirubinRelease before draw
Fist clenchingFalsely ↑ potassiumRelaxed fist
Drawing above IVDilution; contamination from fluidsDraw from opposite arm
Underfilled citrate tubeFalsely ↑ PT/INR, aPTTFill to the line
EDTA contaminationFalsely ↑ K, ↓ Ca, ↓ Mg, ↓ alkaline phosphataseOrder of draw
Delayed transport (glucose)Glycolysis drops glucose ~7 mg/dL/hrGray top or centrifuge promptly
Ammonia not on iceFalsely ↑ ammoniaPlace on ice immediately
Lactate delayFalsely ↑ lactateGray top or ice
The single most important rule in specimen collection is order of draw: blood culture bottles first, then light blue (citrate), then red/gold (serum), then green (heparin), then lavender (EDTA), then gray (fluoride). Drawing EDTA before citrate causes carryover that falsely elevates PT and aPTT.

Spurious Results to Recognize Immediately

ScenarioMechanismApproach
Hyperkalemia in well patientHemolysis, fist clench, EDTA carryover, thrombocytosis (platelet K release in serum)Repeat in green top; check plasma K
Isolated elevated ALPBone source (growth, Paget, mets), pregnancy (placental)GGT to confirm biliary origin
Low sodium (pseudo)Severe hyperlipidemia, hyperproteinemia, hyperglycemiaDirect ISE; correct for glucose
Low TSHAssay interference (biotin), NTIS, dopamine, steroidsHold biotin 48 hr; check free T4
Elevated troponin without MICKD, myocarditis, sepsis, PEDynamic change, ECG, clinical context
Macrocytosis without anemiaAlcohol, hypothyroid, drugsCheck B12, folate, TSH, liver enzymes
Elevated LDHHemolysis (in vivo or in vitro), tissue injury, lymphomaHaptoglobin, smear
Low albuminMalnutrition, liver disease, nephrotic, inflammation (negative APR)Check context; urine protein

04 RBC Indices & the Anemia Workup

Anemia is defined by the WHO as hemoglobin <13 g/dL in men or <12 g/dL in women. The foundational move in any anemia workup is to classify by mean corpuscular volume (MCV) into microcytic (<80 fL), normocytic (80–100 fL), or macrocytic (>100 fL), then to integrate reticulocyte response and peripheral smear findings. Getting this right the first time avoids the costly habit of ordering scattershot iron/B12/folate/SPEP panels on every anemic patient.

The RBC Indices

IndexNormalMeaning
Hemoglobin (Hb)M 13.5–17.5; F 12.0–15.5 g/dLOxygen-carrying capacity
Hematocrit (Hct)~3 × Hb% of blood volume that is RBCs
MCV80–100 fLAverage RBC volume
MCH27–33 pgHb per RBC
MCHC32–36 g/dLHb concentration per RBC; ↑ in spherocytosis
RDW11.5–14.5%Size variation (anisocytosis); ↑ in IDA, mixed anemias

Microcytic Anemia (MCV <80)

CauseIronTIBCFerritinRDWKey Feature
Iron deficiency (IDA)Ferritin <30 is diagnostic
Anemia of chronic diseaseN or ↑NSequestration; high hepcidin
ThalassemiaNNNNVery low MCV, normal RDW, target cells
SideroblasticNRinged sideroblasts; lead, alcohol, INH
Lead poisoningNNBasophilic stippling
The Mentzer index (MCV/RBC count) helps distinguish IDA from thalassemia: >13 suggests IDA, <13 suggests thalassemia. Ferritin <30 ng/mL is essentially pathognomonic for iron deficiency; ferritin >100 in the presence of iron deficiency is possible only with concurrent inflammation (it is an acute phase reactant).

Normocytic Anemia (MCV 80–100)

Divide by reticulocyte index. A low retic index (<2%) suggests hypoproliferation: anemia of chronic disease, chronic kidney disease (low erythropoietin), early iron deficiency, aplastic anemia, marrow infiltration, and endocrine disease. A high retic index (>2%) suggests either hemolysis or acute blood loss. Key tests: LDH, haptoglobin, indirect bilirubin, peripheral smear, direct antiglobulin test (Coombs), creatinine, EPO level.

Macrocytic Anemia (MCV >100)

CategoryCausesClues
MegaloblasticB12 deficiency, folate deficiency, methotrexate, hydroxyurea, zidovudineHypersegmented neutrophils (>5 lobes), oval macrocytes, pancytopenia
Non-megaloblasticAlcohol, liver disease, hypothyroidism, MDS, reticulocytosisRound macrocytes, target cells (liver), no hypersegmentation
B12 deficiency can present with neurologic symptoms (subacute combined degeneration, paresthesias, ataxia) before anemia develops. Always check methylmalonic acid and homocysteine when B12 is borderline (200–400 pg/mL) — both will be elevated in true deficiency; only homocysteine in folate deficiency.

05 Iron Studies, B12 & Folate

Iron studies are the most commonly misinterpreted panel in hematology. The five components are serum iron, total iron-binding capacity (TIBC), transferrin saturation (iron/TIBC × 100), ferritin, and sometimes soluble transferrin receptor. Each has pitfalls.

Interpretation Framework

MarkerNormalInterpretation Pitfalls
Serum iron60–170 μg/dLDiurnal variation (peak AM); drops in acute illness
TIBC (transferrin)240–450 μg/dL↑ in IDA, pregnancy, OCPs; ↓ in inflammation, malnutrition
Transferrin saturation20–50%<15% suggests IDA; >45% suggests iron overload / hemochromatosis
FerritinM 30–400; F 15–200 ng/mLAcute phase reactant — may be falsely normal/high in IDA + inflammation
Soluble transferrin receptorvaries↑ in iron deficiency; unaffected by inflammation — useful to distinguish IDA from ACD

B12 & Folate

Vitamin B12 (cobalamin) is absorbed in the terminal ileum bound to intrinsic factor secreted by parietal cells. Causes of deficiency include pernicious anemia (autoimmune parietal cell destruction), gastrectomy, terminal ileal disease (Crohn's, resection), bacterial overgrowth, tapeworm (Diphyllobothrium latum), strict vegan diet, and chronic PPI/metformin use. Folate deficiency occurs in malnutrition, alcoholism, pregnancy, hemolysis, methotrexate, trimethoprim, and phenytoin.

FindingB12 DeficiencyFolate Deficiency
MMANormal
Homocysteine
Neurologic symptomsYes (dorsal columns, peripheral nerves)No
RBC folateNormal/lowLow
Anti-intrinsic factor AbPositive in pernicious anemiaNegative
Replacing folate in a B12-deficient patient corrects the anemia but allows the neurologic disease to progress irreversibly. Always check B12 before giving folate in a macrocytic anemia of unclear cause.

06 Reticulocytes & Hemolysis Labs

The reticulocyte count is the single most important test for classifying anemia: it tells you whether the marrow is responding appropriately to the drop in hemoglobin. A raw reticulocyte percentage must be corrected for the degree of anemia, because a 2% retic count in a patient with Hct 15 represents a failed marrow, not a robust response.

Reticulocyte Index Calculation

Absolute reticulocyte count = retic% × RBC count. Corrected retic count = retic% × (patient Hct / 45). Reticulocyte production index (RPI) = corrected retic / maturation factor (1.0 at Hct 45, 1.5 at 35, 2.0 at 25, 2.5 at 15). An RPI >2 suggests appropriate marrow response (hemolysis or acute blood loss); RPI <2 suggests hypoproliferation.

Hemolysis Lab Panel

MarkerChange in HemolysisNotes
LDH↑↑Released from lysed RBCs; also from tissue injury, malignancy
Haptoglobin↓↓Binds free Hb; <25 mg/dL in intravascular hemolysis
Indirect bilirubinUnconjugated — rarely >5 mg/dL in pure hemolysis
ReticulocytesMarrow response (unless suppressed, e.g., parvovirus)
Urine hemosiderinPositiveChronic intravascular hemolysis (PNH)
Direct antiglobulin test (Coombs)PositiveImmune-mediated hemolysis (warm or cold)

Intravascular vs Extravascular

Intravascular hemolysis (mechanical fragmentation, complement-mediated lysis, G6PD with oxidant stress) produces hemoglobinemia, hemoglobinuria, severely reduced haptoglobin, and schistocytes on smear. Extravascular hemolysis (splenic destruction of coated or abnormally shaped RBCs) produces splenomegaly, more modest haptoglobin drop, and spherocytes or other abnormal shapes.

A normal LDH and normal haptoglobin together effectively rule out significant hemolysis. If both are abnormal, peripheral smear + Coombs is the next step to separate autoimmune hemolytic anemia (warm AIHA, cold agglutinin) from microangiopathic hemolysis (TTP, HUS, DIC, HELLP) and from intrinsic RBC defects (hereditary spherocytosis, G6PD, sickle).

07 WBC Differential & Leukocyte Disorders

The total WBC count is less informative than the differential. A normal WBC with a profound left shift, a normal WBC with severe lymphopenia, or an "elevated" WBC that is all mature neutrophils in an exercised patient each tell very different stories.

Normal Differential

Cell TypePercentAbsolute (×109/L)
Neutrophils40–70%1.8–7.5
Lymphocytes20–45%1.0–4.0
Monocytes2–10%0.2–0.8
Eosinophils1–6%0.0–0.5
Basophils0–2%0.0–0.2

Neutrophilia & Left Shift

Neutrophilia (>7.5 ×109/L) reflects infection, inflammation, stress (catecholamines demarginate neutrophils), glucocorticoids, smoking, hematologic malignancy (CML, chronic neutrophilic leukemia), or myeloproliferative disease. A left shift means increased band forms and immature neutrophils (metamyelocytes, myelocytes) in the peripheral blood — a marker of accelerated marrow release typical of severe infection. Toxic granulation, Döhle bodies, and cytoplasmic vacuoles are morphologic features of neutrophils responding to severe bacterial infection.

Neutropenia

ANC (×109/L)CategoryInfection Risk
1.0–1.5MildLow
0.5–1.0ModerateModerate
<0.5SevereHigh; febrile neutropenia is an emergency
<0.2Profound (agranulocytosis)Very high; isolate, empiric antibiotics

Causes include chemotherapy, radiation, drugs (clozapine, methimazole, PTU, sulfa, carbamazepine), viral infection (HIV, EBV, CMV, parvovirus), autoimmune disease, B12/folate deficiency, hypersplenism, congenital syndromes (cyclic neutropenia, Kostmann), and aplastic anemia. Benign ethnic neutropenia is common in patients of African descent and does not confer infection risk.

Lymphocytosis, Monocytosis, Eosinophilia

AbnormalityCommon Causes
LymphocytosisViral infection (EBV, CMV, HIV, hepatitis), pertussis, CLL, ALL
LymphopeniaHIV, steroids, chemo, radiation, sepsis, sarcoidosis, SLE
MonocytosisTB, endocarditis, IBD, CMML, recovery from neutropenia
EosinophiliaNAACP: Neoplasm, Allergy/asthma, Addison's, Collagen vascular, Parasites; also drugs (DRESS), eosinophilic syndromes
BasophiliaCML (classic), allergic reactions, hypothyroidism
Absolute eosinophil count >1.5 ×109/L sustained over 6 months with end-organ damage defines hypereosinophilic syndrome. Acute eosinophilia in a patient on a new medication should prompt consideration of DRESS syndrome (drug rash with eosinophilia and systemic symptoms), a life-threatening reaction.

08 Platelets & Pancytopenia

Normal platelet count is 150–450 ×109/L. Thrombocytopenia is defined as <150, with bleeding risk meaningful <50 and spontaneous bleeding risk substantial <20.

Thrombocytopenia Differential

MechanismCauses
Decreased productionMarrow infiltration, aplastic anemia, chemo/radiation, alcohol, B12/folate, MDS, viral suppression
Increased destruction (immune)ITP, drug-induced (heparin, quinine, sulfa, vancomycin), SLE, HIV, HCV, post-transfusion purpura
Increased destruction (non-immune)DIC, TTP, HUS, HELLP, preeclampsia, mechanical valve, prosthetic, sepsis
SequestrationHypersplenism (cirrhosis, portal hypertension)
DilutionMassive transfusion, crystalloid resuscitation
PseudothrombocytopeniaEDTA-induced platelet clumping — redraw in citrate
Don't Miss

TTP classically presents with the pentad of microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal dysfunction, and fever — but the full pentad is present in only ~40% of cases. Any patient with MAHA plus thrombocytopenia and no alternative explanation should be treated as TTP until ADAMTS13 activity returns. Platelet transfusion in TTP can be catastrophic.

Thrombocytosis

Platelet counts >450 can be reactive (iron deficiency, infection, inflammation, malignancy, post-splenectomy, post-hemorrhage) or primary (essential thrombocythemia, polycythemia vera, CML, primary myelofibrosis). Reactive thrombocytosis rarely requires intervention. Primary thrombocytosis with counts >1000 carries both bleeding and thrombotic risk and is worked up with JAK2, CALR, and MPL mutations.

Pancytopenia

Simultaneous reduction in all three cell lines points to marrow failure or marrow replacement. Differential: aplastic anemia, MDS, acute leukemia, myelofibrosis, marrow infiltration (metastatic cancer, lymphoma, granulomas), megaloblastic anemia (B12/folate), hypersplenism, PNH, drugs, sepsis, SLE, HIV. Peripheral smear plus bone marrow biopsy are the definitive next steps.

09 Peripheral Blood Smear Findings

The peripheral smear remains one of the highest-yield tests in medicine. A single slide can establish the diagnosis of TTP, sickle cell crisis, malaria, acute leukemia, hereditary spherocytosis, or lead poisoning, each of which might be delayed or missed by reliance on indices alone.

RBC Morphology

FindingAppearanceAssociations
SchistocytesFragmented RBCs, helmet cellsMAHA: TTP, HUS, DIC, HELLP, mechanical valve, malignant HTN
SpherocytesDense, round, no central pallorHereditary spherocytosis, warm AIHA, burns
Target cellsBullseye appearanceLiver disease, thalassemia, HbC, post-splenectomy
Sickle cellsCrescent-shapedSickle cell disease/trait
Teardrop cells (dacrocytes)Tear-shapedMyelofibrosis, marrow infiltration
Bite cellsSemicircular defectG6PD deficiency (splenic removal of Heinz bodies)
RouleauxStacked coinsMultiple myeloma, Waldenström's, high fibrinogen
Basophilic stipplingCoarse blue dotsLead poisoning, thalassemia, sideroblastic
Howell-Jolly bodiesNuclear remnantAsplenia, functional hyposplenism
Heinz bodiesDenatured Hb (supravital stain)G6PD deficiency, oxidant stress
Pappenheimer bodiesIron granulesSideroblastic anemia, hemolysis

WBC & Platelet Morphology

FindingMeaning
BlastsAcute leukemia (AML if Auer rods; ALL if no granules)
Auer rodsPathognomonic for AML (especially APL/M3)
Hypersegmented neutrophilsB12 or folate deficiency
Smudge cellsCLL (fragile lymphocytes on smear prep)
Atypical lymphocytesViral infection, classically EBV mononucleosis
Giant plateletsITP, Bernard-Soulier, May-Hegglin
Platelet clumpsPseudothrombocytopenia (EDTA)
If the automated CBC flags a critical low platelet count, always look at the smear or review a manual count before transfusing. Platelet clumping is common and produces spurious severe thrombocytopenia in an asymptomatic patient.

Parasites & Inclusions

FindingOrganism / Meaning
Intra-erythrocytic ring formsMalaria (Plasmodium species); thick and thin smears for species ID and parasitemia quantification
Maltese cross tetradsBabesiosis
Morulae in monocytesEhrlichiosis
Morulae in neutrophilsAnaplasmosis
Borrelia in plasmaRelapsing fever
Trypanosomes in plasmaAfrican or American trypanosomiasis

Malaria species ID on thin smear is based on infected RBC size, presence of Schuffner's stippling (P. vivax/ovale), banana-shaped gametocytes (P. falciparum), and parasitemia percentage — >5% parasitemia with falciparum is severe malaria and warrants IV artesunate and consideration of exchange transfusion.

10 PT/INR, aPTT, TT & Mixing Studies

The standard coagulation panel measures three pathways: PT (prothrombin time, reported as INR) tests the extrinsic and common pathways (factors VII, X, V, II, fibrinogen); aPTT (activated partial thromboplastin time) tests the intrinsic and common pathways (XII, XI, IX, VIII, X, V, II, fibrinogen); TT (thrombin time) tests the final conversion of fibrinogen to fibrin.

Normal Ranges

TestNormalSensitive To
PT11–13.5 secFactor VII, warfarin, liver disease, vitamin K deficiency
INR0.9–1.1Standardized PT; used for warfarin monitoring
aPTT25–35 secFactors VIII, IX, XI, XII; heparin, lupus anticoagulant
TT14–19 secDysfibrinogenemia, heparin, direct thrombin inhibitors
Fibrinogen200–400 mg/dLConsumption (DIC), hepatic failure, dysfibrinogenemia
D-dimer<500 ng/mL FEUFibrin degradation; ↑ in VTE, DIC, pregnancy, surgery, infection, malignancy

The PT/aPTT Matrix

PatternDifferential
↑PT, normal aPTTEarly warfarin, vitamin K deficiency, factor VII deficiency, early liver disease
Normal PT, ↑aPTTHeparin, hemophilia A (VIII) or B (IX), factor XI/XII deficiency, vWD, lupus anticoagulant
↑PT, ↑aPTTWarfarin (late), DIC, liver disease, vitamin K deficiency (severe), common pathway defect, combined deficiency, supratherapeutic heparin
Normal PT, normal aPTT, bleedingPlatelet dysfunction, vWD (mild), factor XIII deficiency, vascular cause

Mixing Studies

When PT or aPTT is prolonged, a mixing study (1:1 mix with normal plasma) distinguishes factor deficiency from inhibitor. If the prolonged time corrects to normal after mixing, the patient has a factor deficiency (the normal plasma supplied the missing factor). If it fails to correct, an inhibitor is present — most commonly a lupus anticoagulant or an acquired factor inhibitor (classically factor VIII inhibitor in acquired hemophilia).

A lupus anticoagulant prolongs aPTT in vitro but causes thrombosis in vivo, not bleeding — the classic paradox. If a patient has an unexplained prolonged aPTT that does not correct on mixing, and no bleeding, think lupus anticoagulant and confirm with dilute Russell's viper venom time.

11 Anticoagulant Monitoring & DIC

Warfarin

Warfarin inhibits vitamin K epoxide reductase, depleting functional factors II, VII, IX, X and proteins C and S. Monitor with INR. Standard target 2.0–3.0 for most indications (AFib, VTE, tissue valves); 2.5–3.5 for mechanical mitral valves and some antiphospholipid syndrome. INR >5 without bleeding: hold doses and consider low-dose oral vitamin K. INR with major bleeding: 4-factor PCC (preferred) plus IV vitamin K; FFP is second-line when PCC unavailable.

Heparin

DrugMonitoringTarget
Unfractionated heparinaPTT or anti-XaaPTT 1.5–2.5 × control; anti-Xa 0.3–0.7 IU/mL
LMWH (enoxaparin)Anti-Xa (only in obesity, renal failure, pregnancy)0.5–1.0 IU/mL (peak, 4 hr post-dose)
FondaparinuxAnti-Xa if needed0.5–1.5 IU/mL
ArgatrobanaPTT1.5–3 × baseline
BivalirudinaPTT or ACTACT 300–400 during PCI

DOACs

Direct oral anticoagulants (apixaban, rivaroxaban, edoxaban, dabigatran) do not require routine monitoring. Apixaban and rivaroxaban are factor Xa inhibitors; dabigatran is a direct thrombin inhibitor. When levels are needed (before surgery, in major bleeding, in extremes of weight or renal function): drug-specific anti-Xa assays for Xa inhibitors; diluted thrombin time or ecarin clotting time for dabigatran. Reversal agents: andexanet alfa for apixaban/rivaroxaban; idarucizumab for dabigatran.

DIC

LabDIC Pattern
Platelets↓↓
PT/INR
aPTT
Fibrinogen
D-dimer↑↑
SchistocytesPresent
Antithrombin
Fibrinogen is an acute phase reactant and starts high in pregnancy, sepsis, and inflammation. A "normal" fibrinogen of 250 mg/dL in a septic parturient may actually represent a 50% drop from baseline and an evolving consumptive coagulopathy. Trend the value, not just the absolute number.

12 Thrombophilia, vWD & HIT

Hereditary Thrombophilia Workup

TestDisorderCaveat
Factor V Leiden (APC resistance)Activated protein C resistanceMost common inherited thrombophilia
Prothrombin G20210AProthrombin gene mutationGenetic test; unaffected by anticoagulation
Protein C activityProtein C deficiencyFalsely low on warfarin
Protein S activityProtein S deficiencyFalsely low on warfarin, pregnancy, OCPs
Antithrombin activityAT deficiencyFalsely low on heparin, acute thrombosis
HomocysteineHyperhomocysteinemiaWeak risk factor

Do not order thrombophilia testing during acute thrombosis or while anticoagulated unless you understand the caveats; many results will be falsely abnormal. The clinical impact is also limited — most testing does not change duration of anticoagulation for a first provoked VTE.

Antiphospholipid Syndrome (APS)

Requires clinical criterion (thrombosis or pregnancy morbidity) plus lab criterion: lupus anticoagulant, anti-cardiolipin IgG/IgM, or anti-β2-glycoprotein I, positive on two occasions >12 weeks apart. The lab triad of prolonged aPTT, positive lupus anticoagulant, and positive anti-cardiolipin defines triple positivity and the highest-risk phenotype.

von Willebrand Disease

TestType 1 (quantitative)Type 2 (qualitative)Type 3 (severe)
vWF antigenN or ↓Absent
Ristocetin cofactor↓ (proportional)↓↓ (disproportionate)Absent
Factor VIIIVariableVery low
aPTTNormal or slightly ↑Variable↑↑

Heparin-Induced Thrombocytopenia (HIT)

The 4Ts score stratifies pre-test probability: Thrombocytopenia (magnitude), Timing (day 5–10 of heparin, or <1 day with recent exposure), Thrombosis or other sequelae, and oTher causes. Score 0–3 = low (<5% probability); 4–5 = intermediate; 6–8 = high. In intermediate or high pre-test probability, send anti-PF4/heparin antibodies (ELISA) and confirm positives with functional assay (serotonin release assay). Stop all heparin (including flushes) and start a non-heparin anticoagulant (argatroban, bivalirudin, fondaparinux).

HIT causes thrombosis, not bleeding. Patients lose 50% of platelets but clot, not bleed. Never transfuse platelets empirically in suspected HIT — it worsens thrombosis.

Factor Assays & Specific Deficiencies

FactorPathwayDeficiency Syndrome
I (fibrinogen)CommonAfibrinogenemia, dysfibrinogenemia, DIC, liver failure
II (prothrombin)CommonWarfarin, liver, vit K deficiency
VCommonParahemophilia; only factor not affected by warfarin; useful marker of liver synthesis
VIIExtrinsicShortest half-life; falls first on warfarin; isolated ↑PT
VIIIIntrinsicHemophilia A; X-linked; vWD (vWF carrier); acute phase reactant
IXIntrinsicHemophilia B (Christmas disease); X-linked
XCommonAmyloidosis (acquired factor X deficiency)
XIIntrinsicHemophilia C; autosomal; bleeding milder, less predictable
XIIIntrinsic (contact)Prolongs aPTT but does NOT cause bleeding; incidental finding
XIIIFibrin stabilizationDelayed bleeding, umbilical stump bleeding, normal PT/aPTT

TEG & ROTEM

Viscoelastic testing (thromboelastography or rotational thromboelastometry) provides a global assessment of clot formation, kinetics, strength, and fibrinolysis in whole blood. Increasingly used in trauma, obstetric hemorrhage, and cardiac surgery to guide goal-directed transfusion: prolonged R time (initiation) suggests need for FFP or factor concentrate; low alpha angle or MA suggests need for fibrinogen or platelets; increased LY30 suggests hyperfibrinolysis warranting tranexamic acid.

13 Sodium, Potassium & Chloride

Sodium & Tonicity

Sodium disorders are fundamentally disorders of water, not of sodium content. Classify hyponatremia by serum osmolality first, then by volume status, then by urine sodium and urine osmolality.

StepTestInterpretation
1Serum osmLow (true hypotonic), normal (pseudo: lipids, protein), high (hypertonic: glucose, mannitol)
2Volume statusHypovolemic, euvolemic, hypervolemic
3Urine osm<100 = appropriate dilution (primary polydipsia, beer potomania); >100 = ADH active
4Urine Na<20 = renal retention (hypovolemia, CHF, cirrhosis); >20 = SIADH, adrenal, renal salt wasting

Hyponatremia causes by category: hypovolemic hypotonic — GI losses, diuretics, adrenal insufficiency, cerebral salt wasting. Euvolemic hypotonic — SIADH, hypothyroidism, glucocorticoid deficiency, primary polydipsia, exercise-associated hyponatremia. Hypervolemic hypotonic — heart failure, cirrhosis, nephrotic syndrome, advanced renal failure.

Correction Limits

Correct chronic hyponatremia slowly: no more than 8 mmol/L in 24 hours, 18 in 48 hours. Overcorrection risks osmotic demyelination syndrome (central pontine myelinolysis). Acute hyponatremia with seizures or severe symptoms can and should be corrected rapidly with 3% saline (100 mL boluses) to raise Na by 4–6 mmol/L acutely.

Hypernatremia

Always implies a water deficit (inability to access water or unable to concentrate urine). Causes: diabetes insipidus (central or nephrogenic), osmotic diuresis, insensible losses in an unconscious patient, hypertonic saline or feedings, salt poisoning. Free water deficit formula: TBW × (Na/140 − 1), where TBW = 0.6 × kg in men, 0.5 × kg in women.

Potassium

Hyperkalemia CauseMechanism
Renal failureDecreased excretion
RAAS blockade (ACEi, ARB, spironolactone)Decreased aldosterone effect
AcidosisH+/K+ exchange across cells
Tissue injury (rhabdo, TLS, hemolysis)Intracellular K release
Insulin deficiency, beta-blockerImpaired cellular uptake
Addison's diseaseAldosterone deficiency
PseudohyperkalemiaHemolysis, fist clench, EDTA contamination

EKG progression in hyperkalemia: peaked T waves (~5.5–6.5) → PR prolongation, loss of P waves (~6.5–7.5) → wide QRS, sine wave (>8) → VF or asystole. Treat with calcium (membrane stabilization), insulin + glucose (shift), beta-agonists (shift), bicarbonate (shift, if acidotic), and removal (loop diuretics, dialysis, potassium binders).

Chloride & Bicarbonate

Chloride typically tracks with sodium but diverges in acid-base disorders. Low chloride with high bicarbonate suggests metabolic alkalosis (vomiting, diuretics); high chloride with low bicarbonate suggests normal anion gap metabolic acidosis (diarrhea, RTA, saline resuscitation).

14 Calcium, Magnesium & Phosphate

Calcium

Total calcium (normal 8.5–10.5 mg/dL) reflects both albumin-bound and free (ionized) calcium. Ionized calcium (normal 1.1–1.3 mmol/L) is the physiologically active form. Correct total calcium for albumin: corrected Ca = measured Ca + 0.8 × (4 − albumin). In critical illness, order ionized calcium directly.

Hypercalcemia CausePTHPTHrPVit D
Primary hyperparathyroidismNN
Malignancy (PTHrP)N
Malignancy (1,25-OH vit D, lymphoma)N↑ 1,25
Granulomatous (sarcoid, TB)N↑ 1,25
Vitamin D toxicityN↑ 25-OH
ThiazidesN or ↑NN
Familial hypocalciuric hypercalcemiaN or slight ↑NN; low urine Ca

Hypocalcemia causes: hypoparathyroidism (post-thyroidectomy, autoimmune), vitamin D deficiency, chronic kidney disease, hypomagnesemia (impairs PTH release), acute pancreatitis, sepsis, citrate toxicity after massive transfusion. Symptoms include perioral numbness, Chvostek and Trousseau signs, tetany, QT prolongation, and seizures.

Magnesium

Normal 1.7–2.4 mg/dL. Hypomagnesemia is common in alcoholism, diarrhea, PPIs, loop and thiazide diuretics, aminoglycosides, refeeding syndrome. Clinically, hypomagnesemia causes refractory hypokalemia (renal K wasting) and refractory hypocalcemia (impaired PTH release) — always replace Mg before or alongside K and Ca in ICU patients. Hypermagnesemia occurs almost exclusively in renal failure or iatrogenic (eclampsia treatment); presents with hyporeflexia and respiratory depression at >10 mg/dL.

Phosphate

Normal 2.5–4.5 mg/dL. Hyperphosphatemia: renal failure, tumor lysis, rhabdomyolysis, hypoparathyroidism. Hypophosphatemia: refeeding, DKA recovery, alcoholism, respiratory alkalosis, phosphate binders, severe burns. Severe hypophosphatemia (<1 mg/dL) causes muscle weakness, respiratory failure (diaphragm), rhabdomyolysis, and hemolysis.

In refeeding syndrome, insulin surge drives potassium, phosphate, and magnesium intracellularly, producing dangerous deficiencies within 24–72 hours of starting feeds in a severely malnourished patient. Start low-calorie feeds, replete phosphate aggressively, and give thiamine before carbohydrate.

15 Renal Function: BUN, Creatinine & eGFR

Creatinine is produced from muscle at a relatively constant rate and cleared by glomerular filtration with a small tubular secretion component. It is the workhorse marker of renal function but is insensitive to early GFR decline and depends on muscle mass, age, sex, and ethnicity.

eGFR Equations

EquationInputsNotes
Cockcroft-GaultAge, weight, sex, creatinineEstimates creatinine clearance; used historically for drug dosing
MDRDCreatinine, age, sex, raceHistorically common; less accurate at high GFR
CKD-EPI (2021)Creatinine, age, sex (race removed)Current standard; most accurate across ranges
Cystatin C-basedCystatin C, age, sexIndependent of muscle mass; confirmatory when creatinine is unreliable

CKD Staging

StageeGFR (mL/min/1.73m2)Description
G1≥90Normal or high; CKD only if markers present (albuminuria, imaging)
G260–89Mildly decreased
G3a45–59Mild–moderate
G3b30–44Moderate–severe
G415–29Severe; prepare for RRT
G5<15Kidney failure

BUN:Creatinine Ratio

RatioInterpretation
>20:1Pre-renal (dehydration, CHF, hemorrhage); GI bleed (protein load); steroids; high-protein diet
10–20:1Normal / intrinsic renal disease
<10:1Low protein intake, liver failure (decreased urea synthesis), rhabdomyolysis (creatinine rises disproportionately), malnutrition, dialysis
Creatinine can rise 1–1.5 mg/dL over the first week of starting an ACE inhibitor in a patient with renal artery stenosis or volume depletion; a rise >30% from baseline warrants investigation and often drug withdrawal.

16 AKI vs CKD & Urine Indices

KDIGO AKI Staging

StageCreatinineUrine Output
1↑0.3 mg/dL in 48 hr, or 1.5–1.9× baseline<0.5 mL/kg/hr × 6–12 hr
22.0–2.9× baseline<0.5 mL/kg/hr × ≥12 hr
33.0× baseline, or ≥4 mg/dL, or RRT initiated<0.3 mL/kg/hr × ≥24 hr or anuria × 12 hr

Pre-Renal vs Intrinsic vs Post-Renal

IndexPre-RenalIntrinsic (ATN)
FENa<1%>2%
FEUrea (on diuretics)<35%>50%
Urine Na<20>40
Urine osm>500<350 (isosthenuria)
BUN:Cr>2010–15
SedimentBland, hyaline castsMuddy brown (granular) casts, RTE cells

Formula: FENa = (UNa × PCr) / (PNa × UCr) × 100. FEUrea is preferred when diuretics are on board because they artificially raise urine sodium and invalidate FENa.

Intrinsic AKI Urinary Findings

FindingCause
Muddy brown granular castsAcute tubular necrosis
RBC castsGlomerulonephritis
WBC castsPyelonephritis, acute interstitial nephritis
EosinophilsAcute interstitial nephritis, atheroembolic disease
Hyaline castsNormal, concentrated urine, prerenal
Waxy / broad castsChronic kidney disease
Crystals (uric acid)Tumor lysis syndrome
Crystals (calcium oxalate)Ethylene glycol poisoning
The distinction between AKI and CKD is clinical and historical, not laboratory. Normochromic normocytic anemia, small kidneys on ultrasound, secondary hyperparathyroidism, and bone disease suggest chronicity. Always look for a prior creatinine to anchor the interpretation.

17 Systematic ABG Interpretation

Every ABG should be interpreted with the same five-step algorithm. Skipping steps is the primary reason clinicians miss mixed disorders.

Five-Step ABG Algorithm

Step 1: Assess pH — acidemia (<7.35) or alkalemia (>7.45)?
Step 2: Identify primary disorder — metabolic (HCO3) or respiratory (PaCO2)?
Step 3: Calculate expected compensation and determine whether the compensation is appropriate.
Step 4: Calculate the anion gap. If elevated, calculate delta-delta to look for hidden disorders.
Step 5: Integrate clinically — what disease produces this pattern in this patient?

Primary Disorders & Expected Compensation

PrimarypHPaCO2HCO3Expected Compensation
Metabolic acidosisWinter's: PaCO2 = 1.5(HCO3) + 8 ± 2
Metabolic alkalosisΔPaCO2 = 0.7 × ΔHCO3
Acute respiratory acidosisslight ↑↑HCO3 1 per 10 ↑PaCO2
Chronic respiratory acidosisnear normal↑HCO3 3.5–4 per 10 ↑PaCO2
Acute respiratory alkalosisslight ↓↓HCO3 2 per 10 ↓PaCO2
Chronic respiratory alkalosisnear normal↓HCO3 4–5 per 10 ↓PaCO2

If the measured PaCO2 is higher than Winter's predicted value, a concurrent respiratory acidosis is present. If lower, a concurrent respiratory alkalosis is present. This is how you detect mixed disorders hidden in an apparently simple acidosis.

Oxygenation

The A–a gradient quantifies gas exchange. PAO2 = FiO2(Patm − 47) − PaCO2/0.8. On room air at sea level, PAO2 ≈ 150 − PaCO2/0.8. Normal A–a gradient < (age/4) + 4. An elevated A–a gradient indicates V/Q mismatch, shunt, or diffusion impairment; a normal A–a gradient with hypoxemia suggests hypoventilation or low FiO2.

The P/F Ratio

PaO2/FiO2 ratio is used for ARDS classification: mild 200–300, moderate 100–200, severe <100 (Berlin definition, with PEEP ≥5 cm H2O). A patient with PaO2 80 on room air (P/F = 381) is very different from a patient with PaO2 80 on FiO2 1.0 (P/F = 80) even though the PaO2 is identical.

18 Anion Gap, Delta-Delta & Mixed Disorders

Anion Gap

Anion gap = Na − (Cl + HCO3). Normal 8–12 mmol/L. Correct for albumin: add 2.5 per 1 g/dL decrease below 4. A patient with albumin 2 has a "corrected" normal AG of 13.

HAGMA — MUDPILES and GOLD MARK

MUDPILESGOLD MARK
MethanolGlycols (ethylene, propylene)
UremiaOxoproline (chronic acetaminophen)
DKAL-Lactate
Propylene glycol / paraldehydeD-Lactate
Isoniazid / IronMethanol
Lactic acidosisAspirin
Ethylene glycolRenal (uremia)
Salicylates / starvationKetones (DKA, alcoholic, starvation)

Non-Gap (Hyperchloremic) Acidosis — HARDUPS

Hyperalimentation (TPN), Acetazolamide, RTA (types 1, 2, 4), Diarrhea, Ureterosigmoidostomy, Pancreatic fistula, Saline (large-volume normal saline resuscitation). Distinguish diarrhea from RTA with urine anion gap: UAG = (UNa + UK) − UCl. Negative UAG (−20 to −50) suggests appropriate renal ammonium excretion (diarrhea, GI loss). Positive UAG suggests impaired renal acidification (RTA).

Delta-Delta & Delta Gap

Delta ratio = (AG − 12) / (24 − HCO3). Interpretation: <0.4 pure non-gap acidosis; 0.4–1 mixed gap and non-gap; 1–2 pure gap acidosis; >2 concurrent metabolic alkalosis or pre-existing chronic respiratory acidosis (compensated high HCO3).

Worked Case

Patient with pH 7.30, PaCO2 30, HCO3 14, Na 140, Cl 100, K 4.0. AG = 140 − (100 + 14) = 26 (elevated, HAGMA). Winter's predicts PaCO2 = 1.5(14) + 8 = 29 ± 2 — measured 30 is appropriate. Delta ratio = (26 − 12)/(24 − 14) = 14/10 = 1.4 — suggests concurrent metabolic alkalosis on top of the HAGMA. Check chloride-responsive cause (vomiting, diuretics) before concluding.

Metabolic Alkalosis: Chloride-Responsive vs Unresponsive

CategoryUrine ClCauses
Chloride-responsive<20 mmol/LVomiting, NG suction, diuretic (remote), volume contraction, post-hypercapnia
Chloride-resistant, hypertensive>20 mmol/LPrimary hyperaldosteronism, Cushing's, renovascular HTN, licorice
Chloride-resistant, normotensive>20 mmol/LBartter, Gitelman, diuretic (current use), severe K depletion, Mg depletion
A patient with prolonged vomiting develops hypochloremic, hypokalemic, metabolic alkalosis with paradoxical aciduria (the kidney exchanges H+ for Na in the face of volume contraction). Correction requires volume with normal saline and potassium repletion.

19 Liver Function Tests

"LFTs" are a misnomer — AST, ALT, ALP, and GGT are markers of hepatocyte injury or cholestasis, not function. True liver function is measured by synthetic markers: albumin, PT/INR, bilirubin (with caveats), and ammonia.

Normal Ranges & Cellular Source

TestNormalSource
ALT7–55 U/LHepatocyte cytoplasm; liver-specific
AST8–48 U/LHepatocytes, muscle, heart, RBCs
ALP40–129 U/LBile duct epithelium, bone, placenta, intestine
GGT9–48 U/LBile ducts; alcohol-inducible
Total bilirubin0.1–1.2 mg/dLHeme breakdown
Direct bilirubin<0.3 mg/dLConjugated; water-soluble
Albumin3.5–5.0 g/dLSynthetic; t½ ~20 days
PT/INR0.9–1.1Synthetic; short-half-life factors

Hepatocellular vs Cholestatic Pattern

PatternAST/ALTALPBilirubinCauses
Hepatocellular↑↑ (>5× ULN)N or slight ↑VariableViral, drug, ischemic, autoimmune, Wilson's
CholestaticN or slight ↑↑↑↑ (direct)Stones, stricture, PBC, PSC, drugs, malignancy
MixedDILI, sepsis, alcoholic hepatitis
Isolated ↑AST/ALTNNNAFLD, hemochromatosis, muscle injury (AST only)
Isolated ↑bilirubin (indirect)NN↑ indirectGilbert's, hemolysis

AST:ALT Ratio

AST:ALT ratio >2 with both <300 U/L is classic for alcoholic hepatitis ("Scotch & toast" — AST for alcohol). AST:ALT >1 in non-alcoholic disease suggests cirrhosis or muscle source. ALT >AST is typical of most other hepatocellular injury (viral, NAFLD early, drug). Transaminases >1000 narrow the differential to ischemic hepatitis, acute viral hepatitis, drug (acetaminophen), autoimmune hepatitis, and Wilson's.

Bilirubin Fractionation

Indirect (unconjugated) hyperbilirubinemia: hemolysis, ineffective erythropoiesis, Gilbert's syndrome, Crigler-Najjar. Direct (conjugated) hyperbilirubinemia: biliary obstruction, hepatocellular disease, Dubin-Johnson, Rotor syndrome, sepsis. A direct fraction >50% of total bilirubin always implies hepatobiliary disease.

In acute liver failure, a falling transaminase level with a rising bilirubin and worsening INR does not indicate recovery — it indicates exhausted hepatocytes and impending need for transplant. Synthetic function (INR, factor V) and clinical encephalopathy drive prognosis, not transaminase trend.

Disease-Specific Serology

ConditionKey Tests
Hepatitis AAnti-HAV IgM (acute), anti-HAV IgG (prior exposure/immunity)
Hepatitis BHBsAg (active), anti-HBs (immunity), anti-HBc IgM (acute), anti-HBc IgG (past), HBeAg (high replication), HBV DNA
Hepatitis CAnti-HCV (screen) → HCV RNA (confirm active); genotype for therapy
Autoimmune hepatitisANA, anti-smooth muscle, anti-LKM, elevated IgG
Primary biliary cholangitisAnti-mitochondrial Ab, elevated ALP, elevated IgM
Primary sclerosing cholangitisp-ANCA, MRCP findings; association with IBD
HemochromatosisTransferrin saturation >45%, ferritin ↑, HFE gene mutation
Wilson's diseaseLow ceruloplasmin, high 24-hr urine copper, Kayser-Fleischer rings
α1-antitrypsin deficiencyLow A1AT level, phenotyping (PiZZ)

Child-Pugh & MELD

Child-Pugh score uses bilirubin, albumin, INR, ascites, and encephalopathy to stratify cirrhosis (A/B/C). MELD score uses bilirubin, INR, creatinine, and sodium to prioritize liver transplant allocation: MELD-Na ≥15 is the traditional threshold for listing. Each component has pitfalls — INR differs across labs (ISI variability), creatinine underestimates dysfunction in sarcopenic patients, and bilirubin can be artifactually elevated from hemolysis.

20 Pancreatic & Cardiac Markers

Pancreatic Enzymes

Lipase (normal <160 U/L) is more specific for pancreatitis than amylase and remains elevated longer (7–14 days vs 3–5 days for amylase). Diagnosis of acute pancreatitis requires 2 of 3: characteristic abdominal pain, lipase >3× ULN, and imaging findings. The magnitude of lipase elevation does not correlate with severity. Amylase is less useful: elevated also in parotitis, small bowel obstruction, mesenteric ischemia, ruptured ectopic pregnancy, DKA, and renal failure.

Cardiac Markers

MarkerRisesPeaksReturnsUses
High-sensitivity troponin1–3 hr12 hr7–10 daysMI diagnosis, risk stratification
CK-MB3–6 hr24 hr48–72 hrReinfarction (because troponin stays elevated)
Myoglobin1–2 hr6–12 hr24 hrObsolete for MI; marker for rhabdomyolysis
BNPhoursdaysHeart failure; <100 rules out; >400 rules in
NT-proBNPhoursdaysAge-adjusted cutoffs; less affected by obesity; accumulates in CKD

Troponin Elevation — Not Always MI

Troponin is cardiac-specific but not MI-specific. Elevation occurs in myocarditis, pericarditis, Takotsubo, sepsis, PE, heart failure exacerbation, renal failure, strenuous exercise, chemotherapy cardiotoxicity, tachyarrhythmia, and trauma. The Fourth Universal Definition of MI requires rise and/or fall of troponin with at least one value above the 99th percentile, plus ischemic symptoms, new ischemic ECG changes, new wall motion abnormality, or angiographic evidence of thrombus.

A stable chronic troponin elevation in a dialysis patient is not an MI. Look for the dynamic change — a >20% rise or fall from baseline combined with symptoms suggests acute injury.

BNP & NT-proBNP Interpretation

SituationBNP CutoffNT-proBNP Cutoff
Rules OUT acute HF<100 pg/mL<300 pg/mL
Gray zone100–400300–900 (<50 yr); age-adjusted above
Rules IN acute HF>400>450 (<50), >900 (50–75), >1800 (>75)

BNP is lower in obesity (adipose clearance) and higher in women, elderly, AFib, PE, pulmonary HTN, sepsis, and CKD. BNP is cleaved by neprilysin, so patients on sacubitril/valsartan will have artificially elevated BNP; follow NT-proBNP instead.

Other Cardiac & Inflammatory Markers

MarkerUse
CRPNon-specific inflammation; >10 mg/L significant; hs-CRP for CV risk
ESRSlow, non-specific; useful in GCA, PMR, osteomyelitis; rises with age
ProcalcitoninBacterial infection marker; guides antibiotic duration in LRTI, sepsis
LactateTissue hypoperfusion, sepsis, ischemia, metformin, beta-agonists, seizure
Ferritin (as APR)Very high (>1000) in AOSD, HLH, iron overload

21 Lipids & Thyroid Studies

Lipid Panel

ComponentOptimalNotes
Total cholesterol<200 mg/dLSum of LDL + HDL + VLDL
LDL<100 (very high risk <55)Usually calculated by Friedewald; direct assay when TG >400
HDL>40 M, >50 FInverse CV risk
Triglycerides<150>500 risks pancreatitis; >1000 emergent
Non-HDL<130Total − HDL; all atherogenic particles
ApoB<90 mg/dLParticle count; superior to LDL in metabolic syndrome
Lp(a)<50 mg/dLGenetic CV risk marker; measure once

Friedewald formula: LDL = TC − HDL − TG/5. Invalid when TG >400 or in type III dyslipidemia. For LDL <70, direct LDL is more accurate.

Thyroid Function Tests

PatternTSHFree T4Free T3Diagnosis
Primary hyperthyroidism↓↓Graves, toxic nodule, thyroiditis
Subclinical hyperthyroidismNNEarly thyroid disease, excess replacement
Primary hypothyroidism↑↑N or ↓Hashimoto's, iodine deficiency, post-ablation
Subclinical hypothyroidismNNTreat if TSH >10 or symptomatic
Central hypothyroidismN or ↓Pituitary/hypothalamic disease
Sick euthyroidN, ↓, or ↑N or ↓↓↓Non-thyroidal illness; low T3 first
T3 toxicosisNEarly Graves, T3-producing adenoma

Thyroid Antibodies

TPO antibody (anti-thyroid peroxidase) — Hashimoto's thyroiditis (positive in ~95%) and Graves (~75%). TSH receptor antibody (TRAb/TSI) — Graves disease, useful in pregnancy and ambiguous presentations. Thyroglobulin antibody — present in Hashimoto's, can interfere with thyroglobulin tumor marker assays in thyroid cancer follow-up.

In ICU patients, TSH and free T4 can both be abnormal from non-thyroidal illness alone. Do not initiate thyroid replacement in a critically ill patient on the basis of an isolated low T3 unless hypothyroidism is clinically suspected — wait for recovery and retest.

22 Diabetes & Glycemic Markers

Diagnostic Criteria (ADA)

TestNormalPrediabetesDiabetes
Fasting glucose<100 mg/dL100–125≥126 (confirmed)
2-hr OGTT<140140–199≥200
HbA1c<5.7%5.7–6.4%≥6.5%
Random glucose≥200 with symptoms

HbA1c Pitfalls

HbA1c reflects average glucose over the prior 8–12 weeks but is unreliable in conditions that alter RBC lifespan: hemolytic anemia (falsely low), recent blood transfusion (dilutional), iron deficiency anemia (falsely high), CKD, hemoglobinopathies (HbS, HbC, HbE — depends on assay), and pregnancy. In these situations use fructosamine (2–3 week window) or continuous glucose monitoring.

Estimated Average Glucose

eAG (mg/dL) = 28.7 × A1c − 46.7. A1c 6% ≈ 126; 7% ≈ 154; 8% ≈ 183; 9% ≈ 212; 10% ≈ 240.

C-Peptide & Insulin

C-peptide distinguishes endogenous from exogenous insulin. Low C-peptide with high insulin suggests exogenous insulin (factitious, suicidal); high C-peptide with high insulin suggests insulinoma, sulfonylurea use, or insulin resistance. The 72-hour fast with measurement of glucose, insulin, C-peptide, and proinsulin remains the gold standard for insulinoma diagnosis.

DKA vs HHS

FeatureDKAHHS
Glucose>250>600
pH<7.3>7.3
Bicarbonate<18>18
KetonesModerate/largeSmall
Anion gapVariable
Effective osmVariable>320
Mental statusUsually alertAltered/obtunded
Euglycemic DKA is increasingly common with SGLT2 inhibitors — the glucose may be <200 but ketosis and acidosis are present. Always check a venous gas and beta-hydroxybutyrate in any diabetic patient on an SGLT2 presenting with nausea, vomiting, or malaise.

23 Adrenal, Pituitary & Bone Chemistry

Cortisol & the HPA Axis

TestUseInterpretation
AM cortisolBaseline<3 μg/dL rules in adrenal insufficiency; >15 rules out
ACTH stim (cosyntropin)Primary vs central AIPeak >18 μg/dL at 30–60 min is normal
Low-dose dex suppressionScreening for Cushing'sMorning cortisol <1.8 rules out; >5 abnormal
24-hr urine free cortisolCushing's screening>3× ULN diagnostic
Late-night salivary cortisolCushing's screeningLoss of diurnal variation
ACTHLocalize Cushing'sLow = adrenal; normal/high = pituitary or ectopic
High-dose dex suppressionDistinguish pituitary from ectopic ACTHPituitary suppresses; ectopic does not

Aldosterone & Renin

Aldosterone-renin ratio (ARR) screens for primary hyperaldosteronism. ARR >20 with aldosterone >15 ng/dL suggests primary aldosteronism — confirm with saline suppression or oral salt loading. Hold spironolactone 4–6 weeks before testing; other antihypertensives have variable effects and should be adjusted if possible.

Pheochromocytoma

Best initial test is plasma free metanephrines (sensitivity >95%) or 24-hour urine metanephrines. Avoid acetaminophen before plasma sampling (assay interference). False positives from stress, TCAs, MAOIs, clonidine withdrawal, labetalol. Confirm with imaging only after biochemical confirmation.

Pituitary

HormoneElevated inLow in
ProlactinProlactinoma, drugs (antipsychotics, metoclopramide), pregnancy, stress, stalk effectHypopituitarism
GH / IGF-1Acromegaly (confirm with OGTT failure to suppress GH)GH deficiency
ACTHCushing's (pituitary or ectopic), primary AIAdrenal Cushing's, secondary AI
FSH/LHPrimary gonadal failure, menopauseCentral hypogonadism

Calcium Homeostasis & Bone

ScenarioCaPhosPTH25-OH D
Primary hyperPTHN or ↓
Secondary hyperPTH (CKD)↓ or N
Vit D deficiency↓ or N
Primary hypoPTHN
Malignancy (PTHrP)N
25-hydroxyvitamin D reflects body stores and is the right test for screening deficiency. 1,25-dihydroxyvitamin D is regulated tightly and is rarely useful except in granulomatous disease and rare hereditary disorders.

Bone Turnover Markers

MarkerMeaning
CTX (C-telopeptide)Bone resorption; monitors antiresorptive therapy
NTX (N-telopeptide)Bone resorption; urine or serum
P1NPBone formation; monitors anabolic therapy (teriparatide)
OsteocalcinBone formation; less commonly used clinically
Bone-specific ALPBone formation; useful in Paget's disease

Sex Hormones & Reproductive Testing

TestUse
Total testosterone (AM)Screen for hypogonadism; <300 ng/dL abnormal in adult men
Free testosteroneWhen SHBG altered (obesity, diabetes, thyroid disease)
EstradiolMenstrual phase-dependent; low in premature ovarian insufficiency
Progesterone (day 21)Confirms ovulation; >3 ng/mL
AMHOvarian reserve; independent of cycle
DHEA-SAdrenal androgen; marked elevation suggests adrenal tumor in hirsutism workup
17-OH progesteroneCongenital adrenal hyperplasia (21-hydroxylase deficiency)
β-hCGPregnancy, germ cell tumors, gestational trophoblastic disease

24 Urinalysis & Microscopy

Dipstick Components

ParameterNormalAbnormal Interpretation
ColorPale yellowRed (blood, myoglobin, beets, rifampin); dark (bilirubin, concentrated); milky (chyle, pus)
Specific gravity1.005–1.030Concentrating ability; fixed 1.010 = isosthenuria (ATN, severe CKD)
pH5.0–8.0Persistently alkaline in UTI (urea-splitting), RTA, vegetarian diet
GlucoseNegativeHyperglycemia, Fanconi, SGLT2 use, pregnancy
ProteinNegative / traceGlomerular disease, orthostatic, febrile, pre-eclampsia; dipstick detects albumin mainly
KetonesNegativeDKA, starvation, alcoholic ketoacidosis; detects acetoacetate, not BHB
BilirubinNegativeDirect hyperbilirubinemia (biliary obstruction, hepatocellular)
Urobilinogen0.1–1.0↑ in hemolysis, hepatocellular; ↓ in complete obstruction
BloodNegativeRBCs, hemoglobin, or myoglobin (positive dipstick, no RBCs on micro = pigment)
Leukocyte esteraseNegativePyuria; UTI, sterile pyuria (TB, interstitial nephritis)
NitritesNegativeEnterobacteriaceae (E. coli, Klebsiella, Proteus); gram-positives and Pseudomonas do not reduce nitrate

Microscopy

Spin 10 mL of urine at 2000 rpm for 5 minutes, decant, and resuspend the pellet. Examine under low and high power. Normal findings include occasional hyaline casts, rare RBCs (<2/hpf), rare WBCs (<5/hpf), and squamous epithelial cells (may indicate contamination if numerous).

ElementSignificance
Dysmorphic RBCs, acanthocytesGlomerular bleeding
Isomorphic RBCsLower tract (stones, tumor, trauma)
WBCs without bacteriaSterile pyuria: TB, atypicals, interstitial nephritis, partially treated
Calcium oxalate (envelope)Hypercalciuria, ethylene glycol poisoning
Uric acid (rhomboid)Gout, tumor lysis, low urine pH
Struvite (coffin lid)Urease-producing infection (Proteus, Klebsiella)
Cystine (hexagonal)Cystinuria
YeastCandiduria; colonization vs infection

Proteinuria Quantification

Dipstick is semiquantitative and detects mainly albumin. Quantify with urine protein:creatinine ratio (spot sample approximates 24-hr protein in g/day) or urine albumin:creatinine ratio for microalbuminuria screening. Normal <30 mg/g; microalbuminuria 30–300; macroalbuminuria >300. Nephrotic range proteinuria >3.5 g/day.

25 Gram Stain & Culture Interpretation

Gram Stain Morphology

MorphologyCommon Organisms
Gram-positive cocci in clustersStaphylococcus (aureus, epidermidis)
Gram-positive cocci in chains/pairsStreptococcus, Enterococcus
Gram-positive diplococci, lancet-shapedStreptococcus pneumoniae
Gram-positive rodsListeria, Corynebacterium, Bacillus, Clostridium
Gram-negative diplococciNeisseria (meningitidis, gonorrhoeae), Moraxella
Gram-negative rodsEnterobacteriaceae (E. coli, Klebsiella), Pseudomonas
Gram-negative coccobacilliHaemophilus, Bordetella, Acinetobacter
Gram-variable / pleomorphicGardnerella, Haemophilus

Blood Culture Interpretation

Standard practice: 2 sets (aerobic + anaerobic, 20 mL each) drawn from separate sites before antibiotics. Time to positivity <12 hours with high-grade organisms suggests true bacteremia; delayed growth at 48–72 hours often represents contamination or low-inoculum organisms. Persistent bacteremia with S. aureus, Candida, or HACEK organisms always warrants endocarditis evaluation.

OrganismTrue Pathogen vs Contaminant
S. aureusAlways a pathogen in blood
S. pneumoniaeAlways a pathogen
Gram-negative rodsAlmost always pathogens
Coagulase-negative StaphUsually contaminant; pathogen in prosthetics, line infection
Bacillus (not anthracis)Usually contaminant
Corynebacterium (non-diphtheriae)Usually contaminant; pathogen in prosthetics
Cutibacterium acnesUsually contaminant; pathogen in prosthetic joints, shunts

Urine Culture Thresholds

ScenarioSignificant Threshold
Clean-catch, symptomatic female≥105 CFU/mL (traditional); ≥102 if pyuria and symptoms
Symptomatic male≥103 CFU/mL
Catheterized≥103 CFU/mL
Suprapubic aspirateAny growth
Asymptomatic bacteriuria≥105 in 2 consecutive samples; do not treat except pregnancy, pre-urologic procedure
A positive urine culture in an elderly patient with altered mental status is not automatically the cause of the delirium. Asymptomatic bacteriuria is extraordinarily common in the elderly and treating it does not improve outcomes — it drives resistance and C. difficile. Look for another source before anchoring on a "UTI."

26 CSF & Body Fluid Analysis

CSF Reference Values

ParameterNormalBacterialViralFungal/TB
Opening pressure10–20 cm H2O↑↑N or slight ↑
WBC<5/μL>1000 (PMNs)10–500 (lymph)100–500 (lymph)
Protein15–45 mg/dL>100N or slight ↑>100
Glucose>60% serum (40–70)<40% serumNormal<40% serum
Gram stainNegativePositive ~60–90%NegativeNegative (AFB or India ink)

CSF collected in 4 tubes traditionally: tube 1 cell count and chemistries, tube 2 microbiology, tube 3 special studies, tube 4 second cell count (to compare RBC counts for traumatic tap vs SAH). In traumatic tap, RBCs decrease tube 1 to tube 4; in SAH, they remain the same and xanthochromia develops after ~4–12 hours.

Pleural Fluid — Light's Criteria

Exudate if any one of: pleural protein/serum protein >0.5, pleural LDH/serum LDH >0.6, or pleural LDH >2/3 ULN of serum LDH. Transudates are typically bilateral and due to CHF, cirrhosis, or nephrotic syndrome. Exudates suggest infection, malignancy, PE, autoimmune, or pancreatitis. Additional useful tests: pH <7.2 suggests empyema or complicated parapneumonic effusion requiring drainage; glucose <60 in effusion suggests rheumatoid, empyema, TB, or malignancy; amylase ↑ in pancreatitis and esophageal rupture; triglycerides >110 mg/dL in chylothorax.

Ascitic Fluid — SAAG

Serum-ascites albumin gradient = serum albumin − ascites albumin. SAAG ≥1.1 g/dL indicates portal hypertension (cirrhosis, heart failure, Budd-Chiari, massive liver mets); SAAG <1.1 suggests non-portal etiology (peritoneal carcinomatosis, TB peritonitis, pancreatic ascites, nephrotic syndrome). In suspected spontaneous bacterial peritonitis (SBP), PMN count ≥250/μL is diagnostic — treat empirically with 3rd-generation cephalosporin while awaiting culture.

Synovial Fluid

ClassAppearanceWBCPMN%Examples
NormalClear<200<25%
Non-inflammatory (I)Clear yellow200–2000<25%OA, trauma
Inflammatory (II)Cloudy2000–50,000>50%Gout, pseudogout, RA, SLE
Septic (III)Purulent>50,000 (often >100k)>75%Bacterial arthritis
Hemorrhagic (IV)BloodyVariesVariesTrauma, coagulopathy, PVNS

Crystal analysis under polarized light: monosodium urate (gout) = needle-shaped, negatively birefringent, yellow when parallel to axis. Calcium pyrophosphate (pseudogout) = rhomboid, positively birefringent, blue when parallel to axis.

A septic joint and a crystal arthropathy can coexist. A gram stain positive for organisms or a clinical picture of severe monoarthritis warrants washout and cultures even if crystals are present.

Autoimmune Serology Quick Reference

AntibodyDisease Association
ANASLE screen (sensitive, not specific); positive in many autoimmune and healthy people
Anti-dsDNASLE (specific); tracks disease activity, renal involvement
Anti-SmithSLE (highly specific, low sensitivity)
Anti-Ro (SSA) / La (SSB)Sjögren's, SLE, neonatal lupus, congenital heart block
Anti-histoneDrug-induced lupus (hydralazine, procainamide, INH)
Anti-centromereLimited scleroderma (CREST)
Anti-Scl-70 (topoisomerase)Diffuse scleroderma
Anti-Jo-1Polymyositis/dermatomyositis with ILD
Anti-CCPRheumatoid arthritis (more specific than RF)
RFRA; also Sjögren's, cryoglobulinemia, hepatitis C
c-ANCA (PR3)Granulomatosis with polyangiitis
p-ANCA (MPO)Microscopic polyangiitis, EGPA, drug-induced
Anti-GBMGoodpasture syndrome
Anti-phospholipid (LA, aCL, β2GPI)Antiphospholipid syndrome
Anti-TTG IgACeliac disease (with total IgA to rule out deficiency)

Tumor Markers

MarkerUseCaveats
PSAProstate cancer screening/monitoringBPH, prostatitis, trauma elevate
CEAColon cancer surveillanceSmoking, IBD, pancreatitis elevate
CA 19-9Pancreatic, biliary cancerLewis-negative patients don't produce; elevated in cholestasis
CA-125Ovarian cancer surveillanceMenstruation, endometriosis, PID, cirrhosis elevate
AFPHCC, germ cell tumorsPregnancy, hepatitis elevate
β-hCGGerm cell tumors, GTD, pregnancy
LDHLymphoma, germ cell tumor prognosisNon-specific
ThyroglobulinThyroid cancer recurrence (post-thyroidectomy)Interference from anti-thyroglobulin antibodies
Chromogranin ANeuroendocrine tumorsPPI use elevates

27 Toxicology Screens & Drug Levels

Urine Drug Screen (Immunoassay)

TargetDetection WindowFalse PositivesFalse Negatives
Amphetamines2–4 daysPseudoephedrine, bupropion, selegiline, trazodone, labetalolMDMA may not cross-react
Cocaine (benzoylecgonine)2–4 daysVery few; highly specific
Opiates2–3 daysPoppy seeds, quinolones, rifampinDoes not detect oxycodone, methadone, fentanyl, tramadol, buprenorphine
Benzodiazepines3–30 daysSertraline, oxaprozinMisses clonazepam, lorazepam on some assays
Cannabinoids (THC)3–30+ days (chronic)Dronabinol, PPIs, efavirenzSynthetic cannabinoids not detected
PCP7–14 daysKetamine, dextromethorphan, venlafaxine, tramadol
Methadone3–7 daysQuetiapine, verapamil, diphenhydramine
A "negative opiate" screen does not exclude opioid overdose — fentanyl, oxycodone, methadone, tramadol, and buprenorphine are routinely missed by immunoassay. In an undifferentiated coma with pinpoint pupils, give naloxone empirically regardless of screen result.

Acetaminophen & Salicylates

Acetaminophen level at 4 hours post-ingestion plotted on the Rumack-Matthew nomogram determines N-acetylcysteine therapy. Treat above the treatment line (>150 μg/mL at 4 hours). For staggered ingestions or unknown timing, treat empirically. Salicylate level: therapeutic 10–30 mg/dL; toxicity >40; severe >80. Mixed respiratory alkalosis (early) + anion gap metabolic acidosis (later) is pathognomonic.

Therapeutic Drug Monitoring

DrugTrough / PeakTarget
VancomycinTrough (AUC-based preferred)Trough 15–20 mg/L (serious infection); AUC 400–600
Gentamicin (conventional)Peak / troughPeak 5–10; trough <2
Gentamicin (extended-interval)Random level, Hartford nomogram
TobramycinSame as gentamicin
AmikacinPeak 20–30; trough <5
DigoxinTrough (>6 hr post dose)0.5–2.0 ng/mL; >2.0 toxic
LithiumTrough (12 hr)0.6–1.2 mEq/L; >1.5 toxic
PhenytoinTrough10–20 μg/mL (free 1–2); correct for albumin
ValproateTrough50–100 μg/mL
CarbamazepineTrough4–12 μg/mL
TacrolimusTrough5–20 ng/mL (indication-specific)
CyclosporineTrough100–300 ng/mL
SirolimusTrough5–15 ng/mL
TheophyllineLevel5–15 μg/mL

Antiepileptic & Immunosuppressant Monitoring

Phenytoin is heavily protein-bound. In hypoalbuminemia (common in hospitalized patients), the total level underestimates the free (active) drug. Correct: corrected phenytoin = measured / (0.2 × albumin + 0.1). In severe hypoalbuminemia or renal failure, measure free phenytoin directly.

Osmolar Gap & Toxic Alcohols

Calculated osm = 2(Na) + glucose/18 + BUN/2.8 + ethanol/4.6. Osmolar gap = measured − calculated. Normal <10. Elevated in methanol, ethylene glycol, isopropanol, mannitol, propylene glycol, and severe ketoacidosis. Combination of elevated anion gap + elevated osmolar gap + metabolic acidosis suggests toxic alcohol poisoning — treat with fomepizole and consider dialysis.

28 Critical Values, Formulas & Reference

Master Formula Reference

FormulaCalculation
Anion gapNa − (Cl + HCO3); normal 8–12
Corrected AG (albumin)AG + 2.5 × (4 − albumin)
Delta ratio(AG − 12) / (24 − HCO3)
Winter's formulaPaCO2 = 1.5(HCO3) + 8 ± 2
Serum osmolality2(Na) + Glc/18 + BUN/2.8
Osmolar gapMeasured osm − calculated osm (normal <10)
Corrected Na (hyperglycemia)Measured Na + 1.6 × (Glc − 100)/100
Corrected Ca (albumin)Ca + 0.8 × (4 − albumin)
Free water deficitTBW × (Na/140 − 1); TBW = 0.6 × kg (M), 0.5 × kg (F)
FENa(UNa × PCr) / (PNa × UCr) × 100
FEUrea(UUrea × PCr) / (PUrea × UCr) × 100
Cockcroft-Gault CrCl[(140 − age) × weight] / (72 × Cr); × 0.85 if female
Corrected reticulocyteRetic% × (Hct / 45)
Mentzer indexMCV / RBC count; >13 IDA, <13 thalassemia
Friedewald LDLTC − HDL − TG/5 (invalid if TG >400)
A–a gradientPAO2 − PaO2; normal < (age/4) + 4
P/F ratioPaO2 / FiO2
eAG from A1c28.7 × A1c − 46.7
Corrected phenytoinMeasured / (0.2 × albumin + 0.1)

Quick Reference — Expected Compensation

DisorderExpected
Metabolic acidosis↓PaCO2 = 1.2 × ↓HCO3
Metabolic alkalosis↑PaCO2 = 0.7 × ↑HCO3
Acute respiratory acidosis↑HCO3 = 1 per 10 ↑PaCO2
Chronic respiratory acidosis↑HCO3 = 3.5 per 10 ↑PaCO2
Acute respiratory alkalosis↓HCO3 = 2 per 10 ↓PaCO2
Chronic respiratory alkalosis↓HCO3 = 5 per 10 ↓PaCO2

High-Yield Clinical Pearls

Core Interpretive Rules

1. Never act on a critical value without looking at the patient — pre-analytic error is the single most common cause of spurious panic values.
2. Always correct: calcium for albumin, sodium for glucose, phenytoin for albumin, reticulocytes for hematocrit, anion gap for albumin.
3. The peripheral smear is faster and cheaper than any molecular test and frequently provides the diagnosis before the panel returns.
4. Trend matters more than absolute value — one creatinine is a data point; three creatinines are a diagnosis.
5. Test characteristics depend on pre-test probability. A test that rules out disease in a low-probability patient may be useless in a high-probability patient.
6. Every elevated lactate, troponin, or d-dimer has a differential beyond its textbook cause; do not anchor on a single mechanism.
7. Repeat before you react — especially for borderline potassium, calcium, and thyroid function values.
8. Reference ranges are statistical, not physiological: 1 in 20 "abnormal" results in healthy people is expected.
9. Know the assay limitations of every test you order — HbA1c in hemoglobinopathy, troponin in CKD, d-dimer in pregnancy, phenytoin in hypoalbuminemia.
10. When the labs do not fit the clinical picture, doubt the labs first — but never long.

Critical Value Callback Checklist

ValueImmediate Action
K >6.5ECG, calcium gluconate, insulin/glucose, albuterol, repeat K
K <2.5ECG, IV K replacement (peripheral max 10 mEq/hr), check Mg
Na <120 (symptomatic)3% saline bolus; correct <8 mmol/L/24 hr
Glucose <40D50 1 amp IV; recheck in 15 min; address cause
Glucose >500 + acidosisDKA/HHS protocol; IV fluids, insulin drip, K replacement
Hb <6.5Type and cross, transfuse (unless chronic stable)
Platelets <10Transfuse if bleeding or before procedure; not in TTP/HIT
INR >5 (no bleeding)Hold warfarin; oral vit K 2.5–5 mg
INR >5 (bleeding)4F-PCC + IV vit K 10 mg
pH <7.2Identify cause; treat underlying; consider bicarb in severe acidemia
Lactate >4Resuscitate, source control, sepsis bundle
Troponin rising + ACSAspirin, heparin, cath lab evaluation
Ca >14IV fluids, calcitonin, bisphosphonate; treat cause
Ca <7IV calcium gluconate if symptomatic; replace Mg
Ammonia >100 + encephalopathyLactulose, rifaximin; identify precipitant

Abbreviations

ABG = arterial blood gas; ACD = anemia of chronic disease; ACTH = adrenocorticotropic hormone; ADAMTS13 = von Willebrand factor-cleaving protease; AFP = alpha-fetoprotein; AG = anion gap; AKI = acute kidney injury; ALP = alkaline phosphatase; ALT = alanine aminotransferase; ANA = antinuclear antibody; ANC = absolute neutrophil count; APS = antiphospholipid syndrome; aPTT = activated partial thromboplastin time; AST = aspartate aminotransferase; ATN = acute tubular necrosis; BHB = beta-hydroxybutyrate; BMP = basic metabolic panel; BNP = B-type natriuretic peptide; BUN = blood urea nitrogen; CBC = complete blood count; CCP = cyclic citrullinated peptide; CK = creatine kinase; CKD = chronic kidney disease; CMP = comprehensive metabolic panel; CRP = C-reactive protein; CSF = cerebrospinal fluid; CTX = C-telopeptide; DIC = disseminated intravascular coagulation; DKA = diabetic ketoacidosis; DOAC = direct oral anticoagulant; EDTA = ethylenediaminetetraacetic acid; eGFR = estimated GFR; FEUrea = fractional excretion of urea; HAGMA = high anion gap metabolic acidosis; HbA1c = glycated hemoglobin; HIT = heparin-induced thrombocytopenia; HHS = hyperosmolar hyperglycemic state; IDA = iron deficiency anemia; INR = international normalized ratio; LDH = lactate dehydrogenase; LFT = liver function test; LMWH = low molecular weight heparin; MAHA = microangiopathic hemolytic anemia; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular Hb concentration; MCV = mean corpuscular volume; MDS = myelodysplastic syndrome; MELD = Model for End-Stage Liver Disease; NPV = negative predictive value; OGTT = oral glucose tolerance test; PBC = primary biliary cholangitis; PCC = prothrombin complex concentrate; PE = pulmonary embolism; PMN = polymorphonuclear; PPV = positive predictive value; PSC = primary sclerosing cholangitis; PT = prothrombin time; RDW = red cell distribution width; RPI = reticulocyte production index; RTA = renal tubular acidosis; SAAG = serum-ascites albumin gradient; SBP = spontaneous bacterial peritonitis; SIADH = syndrome of inappropriate ADH; SLE = systemic lupus erythematosus; TIBC = total iron-binding capacity; TSH = thyroid stimulating hormone; TT = thrombin time; TTP = thrombotic thrombocytopenic purpura; ULN = upper limit of normal; vWD = von Willebrand disease; vWF = von Willebrand factor.

Final Integration

Laboratory interpretation is ultimately pattern recognition grounded in physiology. The best clinicians do not memorize isolated values; they build internal narratives that explain why a set of numbers makes sense (or doesn't) in a particular patient. When a panel comes back, ask four questions: What is abnormal? Why might this be abnormal? Does the pattern fit a known disease? What is the next test that will confirm or refute my working diagnosis? This discipline — applied to every panel, every time — is what separates clinicians who act on lab results from those who drown in them.

The chapters above work as a reference map, but the most important skill is the habit of returning to first principles whenever a result doesn't fit: verify the specimen, check for confounders, correct for albumin or glucose when applicable, look at the trend not the snapshot, and tie the pattern back to physiology. A clinician who does this consistently will out-perform any diagnostic algorithm, because the clinical question is always richer than the single number. And when the number truly is the answer — a critical potassium, a positive blood culture, a troponin rising on serial draws — the cost of hesitation is measurable in hours of injury. The work of lab interpretation is therefore equal parts skepticism and decisiveness, and both must be practiced deliberately.

Common Interpretive Traps Worth Memorizing

TrapCorrect Approach
Treating pseudohyperkalemiaVerify non-hemolyzed plasma K before acting
Anchoring on a "UTI" in the elderlyLook for real source of delirium; ASB is usually innocent
Missing TTP in thrombocytopenia + MAHANever transfuse platelets; start plasma exchange
Folate before checking B12Always measure B12; neurologic disease may progress
Dismissing normal lactate in sepsis20% of septic shock has normal lactate
Missing euglycemic DKA on SGLT2Check gas + ketones regardless of glucose
Reading d-dimer without pre-test probabilityAlways apply Wells/Geneva before ordering
Treating subclinical hypothyroidism automaticallyTSH 5–10 — treat selectively
Overcorrecting chronic hyponatremiaStrict limits; ODS is permanent
Equating ferritin with iron status in inflammationUse TSAT, sTfR, or empiric iron trial
The goal of lab interpretation is not to explain every abnormal value. It is to decide what to do next. A result that does not change action is a result that did not need to be ordered. A result that does change action must be acted on decisively, even when imperfect. The discipline lives in that distinction.